CYRX
Cryoport, Inc.
NASDAQ · Industrials · Integrated Freight & Logistics · US
$16.76
+1.90%Oct 22, 2026, 12:00 UTC
Cryoport announced that it will report financial results for the third quarter ended September 30, 2026, on November 5, 2026, after U.S. markets close.
Source:Aug 6, 2026, 20:05 UTC
Cryoport reported its second quarter 2026 financial results, with revenue growing 8% year-over-year to $49.0 million and Life Sciences Services revenue up 15%, BioStorage/BioServices revenue up 25%, supporting 779 global clinical trials and 22 commercially approved cell and gene therapies as of June 30, 2026.
Jun 25, 2026, 12:00 UTC
Cryoport's IntegriCell cryopreservation services were selected by Verismo Therapeutics to support its clinical KIR-CAR T cell therapy programs.
Source: